275 related articles for article (PubMed ID: 10023673)
1. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
[TBL] [Abstract][Full Text] [Related]
2. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
3. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
4. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
Jho Eh; Lomvardas S; Costantini F
Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
[TBL] [Abstract][Full Text] [Related]
5. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
6. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
[TBL] [Abstract][Full Text] [Related]
8. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
9. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
10. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta.
Faux MC; Coates JL; Catimel B; Cody S; Clayton AH; Layton MJ; Burgess AW
Oncogene; 2008 Oct; 27(44):5808-20. PubMed ID: 18591934
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
Hagen T; Vidal-Puig A
Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding.
Webster MT; Rozycka M; Sara E; Davis E; Smalley M; Young N; Dale TC; Wooster R
Genes Chromosomes Cancer; 2000 Aug; 28(4):443-53. PubMed ID: 10862053
[TBL] [Abstract][Full Text] [Related]
14. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
[TBL] [Abstract][Full Text] [Related]
16. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
[TBL] [Abstract][Full Text] [Related]
17. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin.
Kim SI; Park CS; Lee MS; Kwon MS; Jho EH; Song WK
Biochem Biophys Res Commun; 2004 Apr; 317(2):478-83. PubMed ID: 15063782
[TBL] [Abstract][Full Text] [Related]
19. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
Willert K; Shibamoto S; Nusse R
Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
